Susquehanna International Group
BXRX

Susquehanna International Group’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Susquehanna International Group’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16
Closed -$17K – 13976
2021
Q2 		$17K Sell
16
-39
-71% -$51K ﹤0.01% 12426
2021
Q1 		$100K Buy
55
+36
+189% +$72K ﹤0.01% 11864
2020
Q4 		$26K Sell
19
-45
-70% -$92.1K ﹤0.01% 10861
2020
Q3 		$249K Buy
64
+53
+482% +$240K ﹤0.01% 9077
2020
Q2 		$63K Buy
+11
New +$52.8K ﹤0.01% 9690

Susquehanna International Group's BXRX Position: Q4 2023 in Review

Susquehanna International Group sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q4 2023, closing a stake of 10,699 shares — an estimated $3.96K sold.

Susquehanna International Group first reported a position in BXRX in Q2 2020 and held it in 8 quarters. The position peaked at $283K in Q2 2020. 2 funds tracked by Wall St. Rank hold BXRX as of Q4 2023.

  • Susquehanna International Group reported no remaining Baudax Bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 10,699 Baudax Bio, Inc. Common Stock shares in Q4 2023, an estimated $3.96K.
  • Susquehanna International Group first reported a position in Baudax Bio, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Susquehanna International Group's Baudax Bio, Inc. Common Stock position peaked at $283K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.